Jenny Meinhardt

Jenny Meinhardt

Auto-generated profile, based on publicly available information

Jenny Meinhardt

Charité–Universitätsmedizin Berlin, Berlin

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2023 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
JMJenny Meinhardt
Jenny Meinhardt
SSSimon Streit
Simon Streit
CDCarsten Dittmayer
Carsten Dittmayer
RMRegina V. Manitius
Regina V. Manitius
HRHelena Radbruch
Helena Radbruch
FHFrank L. Heppner
Frank L. Heppner

16 February 2024 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JRJosefine Radke
Josefine Radke
JMJenny Meinhardt
Jenny Meinhardt
TATom Aschman
Tom Aschman
RCRobert Lorenz Chua
Robert Lorenz Chua
VFVadim Farztdinov
Vadim Farztdinov
HRHelena Radbruch
Helena Radbruch

14 January 2021 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
MOMatthias Ochs
Matthias Ochs
STSara Timm
Sara Timm
SESefer Elezkurtaj
Sefer Elezkurtaj
DHDavid Horst
David Horst
JMJenny Meinhardt
Jenny Meinhardt
MWMartin Witzenrath
Martin Witzenrath
Electron microscopy reveals collapse induration with alveolar epithelial cell death, basal lamina denudation, collapse and sealing of alveoli in COVID-19. This indicates surfactant dysfunction and alveolar instability as factors for initiation of fibrosis.

8 May 2025 in New England Journal of Medicine
Verified
Journal Article
Closed access
FSFranziska Scheibe
Franziska Scheibe
JMJulia Melchert
Julia Melchert
HRHelena Radbruch
Helena Radbruch
ESEberhard Siebert
Eberhard Siebert
TBTill D. Best
Till D. Best
KRKlemens Ruprecht
Klemens Ruprecht

1 July 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
SGSelina Greuel
Selina Greuel
JIJana Ihlow
Jana Ihlow
MDMihnea-Paul Dragomir
Mihnea-Paul Dragomir
SSSimon Streit
Simon Streit
VCVictor M Corman
Victor M Corman
SESefer Elezkurtaj
Sefer Elezkurtaj
Studies on the coronavirus disease 2019 (COVID-19) usually focus on middle aged and older adults. However, younger patients may present with severe COVID-19 and potentially fatal outcomes. For optimized, more specialized therapeutic regimens in this particular patient group, a better understanding of underlying pathomechanisms is of uttermost importance. This study investigates relevant pre-existing medical conditions, clinical histories and autopsy findings, together with SARS-CoV-2-RNA, determined by qPCR, and laboratory data in six COVID-19 decedents at an age of 50 years or younger who were autopsied at the Charité University Hospital. From a total of 76 COVID-19 patients who underwent an autopsy at our institution, 6 (7.9%) were 50 years old or younger. Most COVID-19 decedents of younger age presented with pre-existing medical conditions prior to SARS-CoV-2 infection. These included overweight and obesity, arterial hypertension, asthma, obstructive sleep apnea as well as graft-versus-host disease following cancer and bone marrow transplantation. Furthermore, clinical histories and autopsy results revealed a disproportionally high prevalence of thromboembolism and ischemic organ damage in this patient cohort. Histopathology and laboratory results indicated coagulopathies, signs of immune dysregulation and liver damage. In conclusion, pre-existing health conditions may increase the risk of severe and fatal COVID-19 in younger patients who may be especially prone to developing thromboembolic complications, immune dysregulation and liver damage.

1 January 2021 in The Lancet
Verified
Journal Article
Open access
CDCarsten Dittmayer
Carsten Dittmayer
JMJenny Meinhardt
Jenny Meinhardt
HRHelena Radbruch
Helena Radbruch
JRJosefine Radke
Josefine Radke
BHBarbara Ingold Heppner
Barbara Ingold Heppner
MLMichael Laue
Michael Laue